FIRST MANHATTAN CO. LLC. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,721,000
-0.2%
21,5100.0%0.01%
+22.2%
Q1 2022$2,727,000
-3.2%
21,5100.0%0.01%0.0%
Q4 2021$2,817,000
-28.3%
21,510
-33.0%
0.01%
-35.7%
Q3 2021$3,928,000
+7.3%
32,1100.0%0.01%
+7.7%
Q2 2021$3,660,000
-5.2%
32,1100.0%0.01%
-23.5%
Q1 2021$3,860,000
-43.1%
32,110
-52.0%
0.02%
-46.9%
Q4 2020$6,789,000
+31.4%
66,8360.0%0.03%
+18.5%
Q3 2020$5,167,000
+26.9%
66,836
+82.9%
0.03%
+12.5%
Q2 2020$4,072,000
-3.0%
36,536
-37.3%
0.02%
-11.1%
Q1 2020$4,197,000
-4.4%
58,3000.0%0.03%
+22.7%
Q4 2019$4,392,00058,3000.02%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders